BioCentury
ARTICLE | Clinical News

NBTXR3: Additional Phase I/II data

July 18, 2016 7:00 AM UTC

Data from 7 evaluable frail and elderly patients with locally advanced squamous cell carcinoma of the oral cavity, tongue or oropharynx in an open-label, dose-escalation, European Phase I/II trial sho...